Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

The search for ESR1 mutations in breast cancer


Two new studies report the identification of activating ESR1 gene mutations in aromatase inhibitor–resistant metastatic breast cancers. This insight into therapeutic resistance suggests new approaches that may be useful in the management of endocrine-resistant breast cancer.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Identification of ESR1 mutations in metastatic breast cancer.

Katie Vicari


  1. Cancer Genome Atlas Network. Nature 490, 61–70 (2012).

  2. Li, S. et al. Cell Rep. 4, 1116–1130 (2013).

    Article  CAS  Google Scholar 

  3. Robinson, D.R. et al. Nat. Genet. 45, 1446–1451 (2013).

    Article  CAS  Google Scholar 

  4. Toy, W. et al. Nat. Genet. 45, 1439–1445 (2013).

    Article  CAS  Google Scholar 

  5. Baselga, J. et al. N. Engl. J. Med. 366, 520–529 (2012).

    Article  CAS  Google Scholar 

  6. Ellis, M.J. et al. Nature 486, 353–360 (2012).

    Article  CAS  Google Scholar 

  7. Carlson, K.E., Choi, I., Gee, A., Katzenellenbogen, B.S. & Katzenellenbogen, J.A. Biochemistry 36, 14897–14905 (1997).

    Article  CAS  Google Scholar 

  8. Lazennec, G., Ediger, T.R., Petz, L.N., Nardulli, A.M. & Katzenellenbogen, B.S. Mol. Endocrinol. 11, 1375–1386 (1997).

    Article  CAS  Google Scholar 

  9. Pakdel, F., Reese, J.C. & Katzenellenbogen, B.S. Mol. Endocrinol. 7, 1408–1417 (1993).

    CAS  PubMed  Google Scholar 

  10. Weis, K.E., Ekena, K., Thomas, J.A., Lazennec, G. & Katzenellenbogen, B.S. Mol. Endocrinol. 10, 1388–1398 (1996).

    CAS  PubMed  Google Scholar 

  11. Zhang, Q.X., Borg, A., Wolf, D.M., Oesterreich, S. & Fuqua, S.A. Cancer Res. 57, 1244–1249 (1997).

    CAS  PubMed  Google Scholar 

  12. Le Goff, P., Montano, M.M., Schodin, D.J. & Katzenellenbogen, B.S. J. Biol. Chem. 269, 4458–4466 (1994).

    CAS  PubMed  Google Scholar 

  13. Ali, S., Metzger, D., Bornert, J.M. & Chambon, P. EMBO J. 12, 1153–1160 (1993).

    Article  CAS  Google Scholar 

  14. Lannigan, D.A. Steroids 68, 1–9 (2003).

    Article  CAS  Google Scholar 

  15. Sherbenou, D.W. & Druker, B.J. J. Clin. Invest. 117, 2067–2074 (2007).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Nancy E Davidson.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oesterreich, S., Davidson, N. The search for ESR1 mutations in breast cancer. Nat Genet 45, 1415–1416 (2013).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer